<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>HUMMEL_BURKITTS_LYMPHOMA_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            HUMMEL_BURKITTS_LYMPHOMA_DN
        </div>
        <div class="card-body">
                <p>BACKGROUND: The distinction between Burkitt&#39;s lymphoma and diffuse large-B-cell lymphoma is unclear. We used transcriptional and genomic profiling to define Burkitt&#39;s lymphoma more precisely and to distinguish subgroups in other types of mature aggressive B-cell lymphomas. METHODS: We performed gene-expression profiling using Affymetrix U133A GeneChips with RNA from 220 mature aggressive B-cell lymphomas, including a core group of 8 Burkitt&#39;s lymphomas that met all World Health Organization (WHO) criteria. A molecular signature for Burkitt&#39;s lymphoma was generated, and chromosomal abnormalities were detected with interphase fluorescence in situ hybridization and array-based comparative genomic hybridization. RESULTS: We used the molecular signature for Burkitt&#39;s lymphoma to identify 44 cases: 11 had the morphologic features of diffuse large-B-cell lymphomas, 4 were unclassifiable mature aggressive B-cell lymphomas, and 29 had a classic or atypical Burkitt&#39;s morphologic appearance. Also, five did not have a detectable IG-myc Burkitt&#39;s translocation, whereas the others contained an IG-myc fusion, mostly in simple karyotypes. Of the 176 lymphomas without the molecular signature for Burkitt&#39;s lymphoma, 155 were diffuse large-B-cell lymphomas. Of these 155 cases, 21 percent had a chromosomal breakpoint at the myc locus associated with complex chromosomal changes and an unfavorable clinical course. CONCLUSIONS: Our molecular definition of Burkitt&#39;s lymphoma clarifies and extends the spectrum of the WHO criteria for Burkitt&#39;s lymphoma. In mature aggressive B-cell lymphomas without a gene signature for Burkitt&#39;s lymphoma, chromosomal breakpoints at the myc locus were associated with an adverse clinical outcome.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M18181">M18181</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:9938">ncbigene:9938</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1396">ncbigene:1396</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:602">ncbigene:602</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:960">ncbigene:960</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6774">ncbigene:6774</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:958">ncbigene:958</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8837">ncbigene:8837</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6282">ncbigene:6282</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1512">ncbigene:1512</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8878">ncbigene:8878</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:54103">ncbigene:54103</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:597">ncbigene:597</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4792">ncbigene:4792</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:29969">ncbigene:29969</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23048">ncbigene:23048</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M18181&#39;, name=&#39;HUMMEL_BURKITTS_LYMPHOMA_DN&#39;), definition=&#34;BACKGROUND: The distinction between Burkitt&#39;s lymphoma and diffuse large-B-cell lymphoma is unclear. We used transcriptional and genomic profiling to define Burkitt&#39;s lymphoma more precisely and to distinguish subgroups in other types of mature aggressive B-cell lymphomas. METHODS: We performed gene-expression profiling using Affymetrix U133A GeneChips with RNA from 220 mature aggressive B-cell lymphomas, including a core group of 8 Burkitt&#39;s lymphomas that met all World Health Organization (WHO) criteria. A molecular signature for Burkitt&#39;s lymphoma was generated, and chromosomal abnormalities were detected with interphase fluorescence in situ hybridization and array-based comparative genomic hybridization. RESULTS: We used the molecular signature for Burkitt&#39;s lymphoma to identify 44 cases: 11 had the morphologic features of diffuse large-B-cell lymphomas, 4 were unclassifiable mature aggressive B-cell lymphomas, and 29 had a classic or atypical Burkitt&#39;s morphologic appearance. Also, five did not have a detectable IG-myc Burkitt&#39;s translocation, whereas the others contained an IG-myc fusion, mostly in simple karyotypes. Of the 176 lymphomas without the molecular signature for Burkitt&#39;s lymphoma, 155 were diffuse large-B-cell lymphomas. Of these 155 cases, 21 percent had a chromosomal breakpoint at the myc locus associated with complex chromosomal changes and an unfavorable clinical course. CONCLUSIONS: Our molecular definition of Burkitt&#39;s lymphoma clarifies and extends the spectrum of the WHO criteria for Burkitt&#39;s lymphoma. In mature aggressive B-cell lymphomas without a gene signature for Burkitt&#39;s lymphoma, chromosomal breakpoints at the myc locus were associated with an adverse clinical outcome.&#34;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;16760442&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9938&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1396&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;602&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;960&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6774&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;958&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8837&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6282&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1512&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8878&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;54103&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;597&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4792&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;29969&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23048&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 5.3.2S&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>